BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16394045)

  • 1. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
    Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.
    Berkowitz RL; Lesser ML; McFarland JG; Wissert M; Primiani A; Hung C; Bussel JB
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):249-55. PubMed ID: 17666597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage.
    Kanhai HH; van den Akker ES; Walther FJ; Brand A
    Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is a non-invasive management allowed for maternofetal alloimmune thrombocytopenia? Experience over a 10-year period].
    Deruelle P; Wibaut B; Manessier L; Subtil D; Vaast P; Puech F; Valat AS
    Gynecol Obstet Fertil; 2007 Mar; 35(3):199-204. PubMed ID: 17306591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
    Radder CM; Brand A; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.
    Thung SF; Grobman WA
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1094-9. PubMed ID: 16157118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal treatment of alloimmune thrombocytopenia.
    Lynch L; Bussel JB; McFarland JG; Chitkara U; Berkowitz RL
    Obstet Gynecol; 1992 Jul; 80(1):67-71. PubMed ID: 1603500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal alloimmune thrombocytopenia.
    Bussel JB; Zabusky MR; Berkowitz RL; McFarland JG
    N Engl J Med; 1997 Jul; 337(1):22-6. PubMed ID: 9203427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow up of children after antenatal treatment for alloimmune thrombocytopenia.
    Radder CM; de Haan MJ; Brand A; Stoelhorst GM; Veen S; Kanhai HH
    Early Hum Dev; 2004 Oct; 80(1):65-76. PubMed ID: 15363839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial fetal platelet counts predict the response to intravenous gammaglobulin therapy in fetuses that are affected by PLA1 incompatibility.
    Gaddipati S; Berkowitz RL; Lembet AA; Lapinski R; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2001 Oct; 185(4):976-80. PubMed ID: 11641688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous umbilical blood sampling in pregnant women with thrombocytopenia. Apropos of 35 cases].
    Razafintsalama T; Coiffic J; Godin O; Lassel L; Chevrant-Breton O; Poulain P
    J Gynecol Obstet Biol Reprod (Paris); 2000 Apr; 29(2):176-84. PubMed ID: 10790630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fetal weight-adjusted intrauterine IgG therapy in neonatal alloimmune thrombocytopenia].
    Giers G; Hoch J; Bald R; Bauer H; Kroll H; Kiefel V; Scharf RE; Hanfland P; Hansmann M; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1996; 33():160-4. PubMed ID: 8974690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of fetal and neonatal alloimmune thrombocytopenia and its antenatal treatment on the medical and developmental outcomes of affected children.
    Ward MJ; Pauliny J; Lipper EG; Bussel JB
    Am J Perinatol; 2006 Nov; 23(8):487-92. PubMed ID: 17094038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmune thrombocytopenia in the fetus and newborn.
    Bussel JB
    Semin Thromb Hemost; 2001 Jun; 27(3):245-52. PubMed ID: 11446658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antenatal diagnosis and management of fetomaternal alloimmune thrombocytopenia.
    Dickinson JE; Marshall LR; Phillips JM; Barr AL
    Am J Perinatol; 1995 Sep; 12(5):333-5. PubMed ID: 8540936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
    Rayment R; Brunskill SJ; Soothill PW; Roberts DJ; Bussel JB; Murphy MF
    Cochrane Database Syst Rev; 2011 May; (5):CD004226. PubMed ID: 21563140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal treatment of neonatal alloimmune thrombocytopenia.
    Bussel JB; Berkowitz RL; McFarland JG; Lynch L; Chitkara U
    N Engl J Med; 1988 Nov; 319(21):1374-8. PubMed ID: 3141811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the management of alloimmune thrombocytopenia.
    Murphy MF; Bussel JB
    Br J Haematol; 2007 Feb; 136(3):366-78. PubMed ID: 17233844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
    Paridaans NP; Kamphuis MM; Taune Wikman A; Tiblad E; Van den Akker ES; Lopriore E; Challis D; Westgren M; Oepkes D
    Fetal Diagn Ther; 2015; 38(2):147-53. PubMed ID: 25896635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.